341
First in Human Study in Healthy Volunteers to Investigate the Safety, Tolerability and Pharmacokinetics of BAY1214784
Condition(s):Clinical Trials, Phase I as TopicLast Updated:March 11, 2015Completed
First in Human: 7227 Clinical Trials, Page 35 of 723
Hide Studies Not Open or Pending
342
Safety, Tolerability and Pharmacokinetic First in Human (FIH) Study for Intravenous (IV) TKM-100802
Condition(s):Ebola Virus InfectionLast Updated:August 7, 2015Terminated
343
First-in-Human Single and Multiple Dose of GLPG1690
Condition(s):HealthyLast Updated:September 22, 2015Completed
344
A First-in-Human Study to Assess Single Doses of APNmAb005 in Healthy Participants
Condition(s):Healthy Volunteers; Tauopathies; Alzheimer DiseaseLast Updated:June 3, 2022Recruiting
345
First-in-Human Single and Multiple Dose of GLPG1205
Condition(s):HealthyLast Updated:October 16, 2013Completed
346
A First-In-Human Study to Evaluate the Safety, Tolerability, and Efficacy of Si-544 in Adults With Atopic Dermatitis
Condition(s):Atopic DermatitisLast Updated:September 28, 2022Recruiting
347
A Study of the Safety and Tolerability of ABBV-467 in Adult Participants With Relapsed/Refractory (R/R) Multiple Myeloma
Condition(s):Multiple Myeloma (MM); CancerLast Updated:July 26, 2021Terminated
348
HAL-MRE1 Subcutaneous Immunotherapy in Ragweed Allergic Patients First-in-human
Condition(s):Rhinitis, Allergic; Rhinoconjunctivitis, AllergicLast Updated:August 6, 2019Completed
349
First-in-human Study of CCW702 in Patients With Metastatic Castration Resistant Prostate Cancer
Condition(s):Metastatic Castration-Resistant Prostate AdenocarcinomaLast Updated:October 3, 2022Active, not recruiting
350
Safety, Tolerability and Pharmacokinetic First in Human (FIH) Study of Intravenous (IV) TKM-100201 Infusion
Condition(s):Ebola Virus InfectionLast Updated:January 9, 2014Terminated